Lovenox

Product NDC: 55154-4028
11-digit product format: 551544028
Labeler code: 55154
Product ID: 55154-4028_ebd70650-9a1a-4922-859c-d14448c43c70
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: enoxaparin sodium
Dosage form: INJECTION
Route: SUBCUTANEOUS
Labeler: Cardinal Health 107, LLC
Application: NDA020164
Marketing category: NDA
Marketing start: 1993-03-29
Substance: ENOXAPARIN SODIUM
Active strength: 40 mg/.4mL
Pharmacologic classes: Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020164-001	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29
N020164-002	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30
N020164-003	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27
N020164-004	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27
N020164-005	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27
N020164-006	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02
N020164-007	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02
N020164-008	LOVENOX (PRESERVATIVE FREE)	ENOXAPARIN SODIUM	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02
N020164-009	LOVENOX	ENOXAPARIN SODIUM	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 8 matching rows.

Application-product, TE code table
Application-product	TE code
N020164-001	AP
N020164-002	AP
N020164-003	AP
N020164-004	AP
N020164-005	AP
N020164-007	AP
N020164-008	AP
N020164-009	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 10 · 378 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-005	LOVENOX (PRESERVATIVE FREE)	100MG/ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD, RS	1998-03-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-006	LOVENOX (PRESERVATIVE FREE)	90MG/0.6ML (150MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / SUBCUTANEOUS		RLD	2000-06-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-007	LOVENOX (PRESERVATIVE FREE)	120MG/0.8ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-008	LOVENOX (PRESERVATIVE FREE)	150MG/ML (150MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	2000-06-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-009	LOVENOX	300MG/3ML (100MG/ML)	INJECTABLE / INTRAVENOUS, SUBCUTANEOUS	AB	RLD	2003-01-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-001	LOVENOX (PRESERVATIVE FREE)	30MG/0.3ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1993-03-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-002	LOVENOX (PRESERVATIVE FREE)	40MG/0.4ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-01-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-003	LOVENOX (PRESERVATIVE FREE)	60MG/0.6ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-004	LOVENOX (PRESERVATIVE FREE)	80MG/0.8ML (100MG/ML)	INJECTABLE / SUBCUTANEOUS	AP	RLD	1998-03-27	`fd3edfee7708…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 9 · 336 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N020164-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-003	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-004	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-005	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-007	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-008	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020164-009	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020164-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-004	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-005	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-007	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-008	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020164-009	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-004	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-005	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-007	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-008	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020164-009	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020164-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-004	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-005	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-007	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-008	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020164-009	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-004	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-005	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-007	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-008	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020164-009	AB	1	`fd3edfee7708…`

Additional Listing Data#

Finished product: Yes
Brand name base: Lovenox
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ENOXAPARIN SODIUM	40 mg/.4mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
8NZ41MIK1O	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
854235	Internal RxNorm lookup
854236	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3d263380-4f44-4fd8-aa2a-e69702ab258f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
33a7d2c8-f5cf-4d97-8510-92190c5e0f12	Product name	7	20240606

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55154-4028-5	Lovenox	0.4 mL in 1 SYRINGE	INJECTION	0.4		18
55154-4028-5	Lovenox	5 in 1 BAG	INJECTION	5		18

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
enoxaparin sodium	ACTIVE INGREDIENT	8NZ41MIK1O	LOVENOX (ENOXAPARIN SODIUM) INJECTION [CARDINAL HEALTH]	7
enoxaparin	ACTIVE MOIETY	E47C0NF7LV	LOVENOX (ENOXAPARIN SODIUM) INJECTION [CARDINAL HEALTH]	7
water	INACTIVE INGREDIENT	059QF0KO0R	LOVENOX (ENOXAPARIN SODIUM) INJECTION [CARDINAL HEALTH]	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55154-4028	LOVENOX (ENOXAPARIN SODIUM) INJECTION [CARDINAL HEALTH 107, LLC]	15	Current NDC, Legacy NDC, 2 package rows	20250507_3d263380-4f44-4fd8-aa2a-e69702ab258f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lovenox	ENOXAPARIN SODIUM	Sanofi-Aventis U.S. LLC	5017a927-2a24-4f27-89f9-27c805bf7d59	2026-05-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020164 application number: NDA020164
Lovenox	ENOXAPARIN SODIUM	Cardinal Health 107, LLC	3d263380-4f44-4fd8-aa2a-e69702ab258f	2026-04-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020164 application number: NDA020164 ndc (product): 55154-4028
Lovenox	ENOXAPARIN SODIUM	Sanofi-Aventis U.S. LLC	de6fb917-a94a-41ea-9d7d-937d4080ffcd	2026-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020164 application number: NDA020164
Enoxaparin sodium	ENOXAPARIN SODIUM	Sanofi-Aventis U.S. LLC	20635579-c92d-4f6c-a332-1096d51002f2	2026-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020164 application number: NDA020164
Enoxaparin Sodium	ENOXAPARIN SODIUM	Fresenius Kabi USA, LLC	21b095d1-5ade-43e9-9114-30fbfb2331c9	2026-02-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020164 application number: NDA020164
Enoxaparin Sodium	ENOXAPARIN SODIUM	Fresenius Kabi USA, LLC	066f27ec-352c-4051-ba29-248e292690db	2026-02-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 020164 application number: NDA020164

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
8NZ41MIK1O	ENOXAPARIN SODIUM	679809-58-6	ENOXAPARIN SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
854235	enoxaparin sodium 40 MG in 0.4 ML Prefilled Syringe	PSN	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854236	Lovenox 40 MG in 0.4 mL Prefilled Syringe	PSN	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854236	0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]	SBD	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854235	0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe	SCD	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854235	0.4 ML ENX sodium 100 MG/ML Prefilled Syringe	SY	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854236	0.4 ML ENX sodium 100 MG/ML Prefilled Syringe [Lovenox]	SY	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854236	0.4 ML Lovenox 100 MG/ML Prefilled Syringe	SY	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854235	enoxaparin sodium 40 MG per 0.4 ML Prefilled Syringe	SY	3d263380-4f44-4fd8-aa2a-e69702ab258f	18
854236	Lovenox 40 MG per 0.4 ML Prefilled Syringe	SY	3d263380-4f44-4fd8-aa2a-e69702ab258f	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55154-4028-5	55154402805	5 SYRINGE in 1 BAG (55154-4028-5) / .4 mL in 1 SYRINGE	5 syringe	1993-03-29	0000-00-00	No	No	Current